{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:21:01Z","timestamp":1783527661273,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06188-z","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:14:44Z","timestamp":1780665284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early relapse under the LoVAS reduced-dose glucocorticoid regimen in ANCA-associated vasculitis: a single-center retrospective observational study"],"prefix":"10.1007","volume":"46","author":[{"given":"Naoki","family":"Nakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8924-8616","authenticated-orcid":false,"given":"Hiroshi","family":"Oiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"6188_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","volume":"83","author":"B Hellmich","year":"2024","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH et al (2024) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis 83:30\u201347. https:\/\/doi.org\/10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"key":"6188_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Peh CA et al (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med 382:622\u2013631. https:\/\/doi.org\/10.1056\/NEJMoa1803537","journal-title":"N Engl J Med"},{"key":"6188_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/ard-2024-226339","volume":"84","author":"S Nagle","year":"2025","unstructured":"Nagle S, Nguyen Y, Guerry MJ et al (2025) Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis. Ann Rheum Dis 84:319\u2013328. https:\/\/doi.org\/10.1136\/ard-2024-226339","journal-title":"Ann Rheum Dis"},{"key":"6188_CR4","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1001\/jama.2021.6615","volume":"325","author":"S Furuta","year":"2021","unstructured":"Furuta S, Nakagomi D, Kobayashi Y et al (2021) Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a randomized clinical trial. JAMA 325:2178\u20132187. https:\/\/doi.org\/10.1001\/jama.2021.6615","journal-title":"JAMA"},{"key":"6188_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/ard-2023-224343","volume":"83","author":"S Furuta","year":"2024","unstructured":"Furuta S, Nakagomi D, Kobayashi Y et al (2024) Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study. Ann Rheum Dis 83:96\u2013102. https:\/\/doi.org\/10.1136\/ard-2023-224343","journal-title":"Ann Rheum Dis"},{"key":"6188_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1\u201311. https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"6188_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222\u2013227. https:\/\/doi.org\/10.1136\/ard.2006.054593","journal-title":"Ann Rheum Dis"},{"key":"6188_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne DRW, Merkel PA, Schall TJ, Bekker P, ADVOCATE Study Group (2021) Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med 384:599\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa2023386","journal-title":"N Engl J Med"},{"key":"6188_CR9","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D et al (2009) Modification and validation of the Birmingham Vasculitis Activity Score version 3. Ann Rheum Dis 68:1827\u20131832. https:\/\/doi.org\/10.1136\/ard.2008.101279","journal-title":"Ann Rheum Dis"},{"key":"6188_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1213277","volume":"369","author":"U Specks","year":"2013","unstructured":"Specks U, Merkel PA, Seo P et al (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 369:417\u2013427. https:\/\/doi.org\/10.1056\/NEJMoa1213277","journal-title":"N Engl J Med"},{"key":"6188_CR11","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00296-011-2136-z","volume":"32","author":"Y Matsumoto","year":"2012","unstructured":"Matsumoto Y, Sada KE, Otsuka F et al (2012) Evaluation of weekly-reduction regimen of glucocorticoids in combination with cyclophosphamide for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis in Japanese patients. Rheumatol Int 32:2999\u20133005. https:\/\/doi.org\/10.1007\/s00296-011-2136-z","journal-title":"Rheumatol Int"},{"key":"6188_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00296-017-3855-6","volume":"38","author":"JC Robson","year":"2018","unstructured":"Robson JC, Dawson J, Cronholm PF et al (2018) Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatol Int 38:675\u2013682. https:\/\/doi.org\/10.1007\/s00296-017-3855-6","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06188-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06188-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06188-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:39:25Z","timestamp":1783525165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06188-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["6188"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06188-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HO has received lecture fees from GlaxoSmithKline, AstraZeneca, UCB Japan, Asahi Kasei Pharma, Chugai Pharmaceutical Co., Ltd., Sandoz, Otsuka Pharmaceutical Co., Ltd., AYUMI Pharmaceutical Corporation, Taisho Pharmaceutical Co., Ltd., Boehringer Ingelheim, and Eisai Co., Ltd. The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study complied with the Declaration of Helsinki, and the institutional review board of Hiroshima City Hiroshima Citizens Hospital approved this study (approval no. 2025\u2009\u2212\u2009115; approval date: October 10, 2025). The need to obtain informed consent from patients was waived in accordance with the regulations for retrospective cohort studies. Information for patients regarding this study was provided on the hospital website.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"During the preparation of this work, the authors used ChatGPT (GPT-5.5 Thinking; OpenAI, accessed in May 2026) to assist with English editing, manuscript refinement, and preparation of the conceptual illustration in Fig.\u00a01A. The authors reviewed and edited the output and take full responsibility for the content of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"137"}}